Original language | English |
---|---|
Pages (from-to) | 565-565 |
Number of pages | 1 |
Journal | Value in Health |
Volume | 5 |
Issue number | 6 |
Publication status | Published - 2002 |
Economic evaluation demonstrates that moxifloxacin IV/PO monotherapy is cost-effective to the Spanish National Healthcare System when compared to IV/PO amoxicillin/clavulanate +/- clarithromycin in the treatment of community-acquired pneumonia
M Drummond, D Becker, M Hux, J Chancellor, I Duprat-Lomon, P P Sagnier
Research output: Contribution to journal › Article › peer-review